ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,066.00
-0.07%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
66,877.88
-0.30%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Erytech Pharma SA (ERYP)

  7. Erytech Pharma SA (ERYP) News

ERYP

Erytech Pharma (ERYP)

Erytech Pharma SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ERYP
DateTimeSourceHeadlineSymbolCompany
06/30/202311:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
06/29/20233:53PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ERYPErytech Pharma SA
06/29/20233:52PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ERYPErytech Pharma SA
06/28/20238:54AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
06/28/20238:53AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
06/21/20236:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
06/12/202310:34AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
05/24/20234:52PMEdgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ERYPErytech Pharma SA
05/24/20238:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
05/16/202310:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
05/09/202310:30AMAllPennyStocks.comMicro Cap Bid Up Right Before Opening BellNASDAQ:ERYPErytech Pharma SA
04/18/20238:21AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
03/23/20239:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
02/14/202312:51PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
02/14/20236:13AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
12/23/20225:09PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
11/22/202211:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
10/14/20226:12AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
08/25/20221:21PMDow Jones NewsErytech Pharma Shares Hit 52-Week Low After Ending Plans for License Application for GraspaNASDAQ:ERYPErytech Pharma SA
08/25/202210:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
06/28/20229:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
05/13/202211:37AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
05/02/20229:48AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
04/28/20228:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
04/27/202212:51PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ERYPErytech Pharma SA
04/25/20224:32PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
03/15/20229:20AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
02/15/20226:30AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ERYPErytech Pharma SA
02/14/20221:49PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
02/10/20228:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
 Showing the most relevant articles for your search:NASDAQ:ERYP

Your Recent History

BIT
P1KE46
BNP Paribas Issuance
COIN
EPYETH
ASX
KNI
Kuniko
DGFX
EVMOSETH
EVMOS
EU
FCP
Fc Do Porto
BOV
BIVW39M
BlackRock Institutional ...
COIN
SRCGBP
TSXV
ACE.H
Ace Aviation
USOTC
OSAP
ProSomnus (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved